|
Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Affymax, Inc. -- AFFY
|
2:00 PM |
Apr 28, 2013 |
PR
|
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and Upcoming Deadline -- AFFY
|
1:36 PM |
Apr 26, 2013 |
PR
|
|
AFFYMAX 96 HOUR SHAREHOLDER ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Large Financial Interests of Important Deadline in Lawsuit Against Affymax, Inc.
|
10:00 PM |
Apr 25, 2013 |
PR
|
|
Anemia Drug Had Early Side Effects
|
6:31 PM |
Mar 29, 2013 |
WSJ.com
|
|
The Daily Docket: Judge Says Creditors Can Vote on Rival Plans for Ahern
|
10:26 AM |
Mar 19, 2013 |
WSJ.com
|
|
Amgen Gains From Affymax's Pain
|
12:30 PM |
Feb 25, 2013 |
Barrons.com
|
|
Affymax Shares Plunge on Drug's Recall
|
10:52 AM |
Feb 25, 2013 |
WSJ.com
|
|
Stocks to Watch: Barnes & Noble, Elan Corp, Affymax
|
9:17 AM |
Feb 25, 2013 |
WSJ.com
|
|
Drug Makers Recall Anemia Medication
|
1:50 PM |
Feb 24, 2013 |
WSJ.com
|
